ArticleJournal of clinical immunology2018
Warts and DADA2: a Mere Coincidence?
Abstract readCase ReportsLetter
In one paragraph
Article in Journal of clinical immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Monogenic etiologies of persistent human papillomavirus infections: A comprehensive systematic review.Genetics in medicine : official journal of the American College of Medical Genetics · 2024Pooled it
- A wide spectrum of phenotype of deficiency of deaminase 2 (DADA2): a systematic literature review.Orphanet journal of rare diseases · 2023Pooled it
- Adenosine deaminase type 2 deficiency: From rare to common.Journal of human immunity · 2026Review
- Dominant negative ADA2 mutations cause ADA2 deficiency in heterozygous carriers.The Journal of experimental medicine · 2025Article
- Human ADA2 Deficiency: Ten Years Later.Current allergy and asthma reports · 2024Review
- Clinical Symptoms, Laboratory Parameters and Long-Term Follow-up in a National DADA2 Cohort.Journal of clinical immunology · 2023Review
- A novel frameshift variant in the ADA2 gene of a patient with a neurological phenotype: a case report.Pediatric rheumatology online journal · 2022Article
- Deficiency of Human Adenosine Deaminase Type 2 - A Diagnostic Conundrum for the Hematologist.Frontiers in immunology · 2022Review
- Adenosine Deaminase 2 Deficiency (DADA2): A Crosstalk Between Innate and Adaptive Immunity.Frontiers in immunology · 2022Review
- Intrinsic Defects in B Cell Development and Differentiation, T Cell Exhaustion and Altered Unconventional T Cell Generation Characterize Human Adenosine Deaminase Type 2 Deficiency.Journal of clinical immunology · 2021Article
- Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment.Clinical rheumatology · 2021Review
- Adult-onset deficiency of adenosine deaminase 2-a case report and literature review.Clinical rheumatology · 2021Review
- Exome sequencing study in a clinical research setting finds general acceptance of study returning secondary genomic findings with little decisional conflict.Journal of genetic counseling · 2021Article
- The Spectrum of the Deficiency of Adenosine Deaminase 2: An Observational Analysis of a 60 Patient Cohort.Frontiers in immunology · 2021Observational
- The Many Faces of a Monogenic Autoinflammatory Disease: Adenosine Deaminase 2 Deficiency.Current rheumatology reports · 2020Review
- Late-Onset EBV Susceptibility and Refractory Pure Red Cell Aplasia Revealing DADA2.Journal of clinical immunology · 2020Article
- Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2).The Journal of allergy and clinical immunology · 2020Article
- Human genetic dissection of papillomavirus-driven diseases: new insight into their pathogenesis.Human genetics · 2020Review
- Homozygous Splice ADA2 Gene Mutation Causing ADA-2 Deficiency.Journal of clinical immunology · 2019Article
- Childhood Hodgkin Lymphoma: Think DADA2.Journal of clinical immunology · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Katrijn ArtsDepartment of Pediatrics, Laboratory for Inborn Errors of Immunity, Department of Microbiology and Immunology, University Hospitals Leuven, KU Leuven, Herestraat 49 - bus 7003, 3000, Leuven, Belgium.
Jenna R E BergersonNational Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bldg 10, Room 12C103, 9000 Rockville Pike, Bethesda, MD, 20892, USA.
Amanda K OmbrelloNational Human Genome Research Institute (NHGRI), NIH, Bethesda, MD, USA.
Morgan SimilukNational Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bldg 10, Room 12C103, 9000 Rockville Pike, Bethesda, MD, 20892, USA.
Andrew J OlerNational Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bldg 10, Room 12C103, 9000 Rockville Pike, Bethesda, MD, 20892, USA.
Anahita AgharahimiNational Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bldg 10, Room 12C103, 9000 Rockville Pike, Bethesda, MD, 20892, USA.
Emily M MaceCenter for Human Immunobiology, Texas Children's Hospital, Houston, TX, USA.
Mike HershfieldDepartments of Medicine and Biochemistry, Duke University, 418 Sands Building, Durham, NC, USA.
Carine WoutersDepartment of Pediatrics, Laboratory for Immunobiology, Department of Microbiology and Immunology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
Lien De SomerDepartment of Pediatrics, Laboratory for Immunobiology, Department of Microbiology and Immunology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
Marie-Anne MorrenDepartment of Dermatology, University Hospitals Leuven, Leuven, Belgium.
Rebeca Perez-de DiegoImmunogenetics of Diseases Laboratory, Innate Immunity Group, IdiPAZ Institute for Health Research, La Paz University Hospital, Madrid, Spain.
Leen MoensDepartment of Pediatrics, Laboratory for Inborn Errors of Immunity, Department of Microbiology and Immunology, University Hospitals Leuven, KU Leuven, Herestraat 49 - bus 7003, 3000, Leuven, Belgium.
Alexandra F FreemanNational Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bldg 10, Room 12C103, 9000 Rockville Pike, Bethesda, MD, 20892, USA. freemaal@mail.nih.gov.
Isabelle MeytsDepartment of Pediatrics, Laboratory for Inborn Errors of Immunity, Department of Microbiology and Immunology, University Hospitals Leuven, KU Leuven, Herestraat 49 - bus 7003, 3000, Leuven, Belgium. isabelle.meyts@uzleuven.be.ORCID 0000-0003-1214-0302
Funding
Primary Immune Deficiency ClinicZIAAI001247 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI FREEMAN, ALEXANDRA · 2019 to 2025
$8.7MAbstract
PubMed holds no abstract for this paper.
Indexed as
GenotypeAdenosine DeaminaseAdultAgammaglobulinemiaAnti-Inflammatory AgentsAutoimmunityChildChild, PreschoolEtanerceptHomozygoteHumansInflammationIntercellular Signaling Peptides and ProteinsMaleMutationPedigreeADA2 protein, humanAdenosine DeaminaseAnti-Inflammatory AgentsEtanerceptIntercellular Signaling Peptides and Proteins
Identifiers
PMID
30386947What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.